51 related articles for article (PubMed ID: 36076506)
1. ZEB1: Catalyst of immune escape during tumor metastasis.
Lu J; Fei F; Wu C; Mei J; Xu J; Lu P
Biomed Pharmacother; 2022 Sep; 153():113490. PubMed ID: 36076506
[TBL] [Abstract][Full Text] [Related]
2. ZEB1 Is Regulated by K811 Acetylation to Promote Stability, NuRD Complex Interactions, EMT, and NSCLC Metastasis.
Perez-Oquendo M; Manshouri R; Tian Y; Fradette JJ; Rodriguez BL; Kundu ST; Gibbons DL
Mol Cancer Res; 2023 Aug; 21(8):779-794. PubMed ID: 37255406
[TBL] [Abstract][Full Text] [Related]
3. Serotonin Receptor HTR2B Facilitates Colorectal Cancer Metastasis via CREB1-ZEB1 Axis-Mediated Epithelial-Mesenchymal Transition.
Li T; Wei L; Zhang X; Fu B; Zhou Y; Yang M; Cao M; Chen Y; Tan Y; Shi Y; Wu L; Xuan C; Du Q; Hu R
Mol Cancer Res; 2024 Jun; 22(6):538-554. PubMed ID: 38381131
[TBL] [Abstract][Full Text] [Related]
4. USP10 Regulates ZEB1 Ubiquitination and Protein Stability to Inhibit ZEB1-Mediated Colorectal Cancer Metastasis.
Sun L; Yu J; Guinney J; Qin B; Sinicrope FA
Mol Cancer Res; 2023 Jun; 21(6):578-590. PubMed ID: 36940483
[TBL] [Abstract][Full Text] [Related]
5. Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer.
Wang D; Du G; Chen X; Wang J; Liu K; Zhao H; Cheng C; He Y; Jing N; Xu P; Bao W; Xi X; Zhang Y; Wang N; Liu Y; Sun Y; Zhang K; Zhang P; Gao WQ; Zhu HH
Cell Death Differ; 2024 Jun; 31(6):779-791. PubMed ID: 38654072
[TBL] [Abstract][Full Text] [Related]
6. Corneal injury repair and the potential involvement of ZEB1.
Jin L; Zhang L; Yan C; Liu M; Dean DC; Liu Y
Eye Vis (Lond); 2024 Jun; 11(1):20. PubMed ID: 38822380
[TBL] [Abstract][Full Text] [Related]
7. Collagen I-induced VCAN/ERK signaling and PARP1/ZEB1-mediated metastasis facilitate OSBPL2 defect to promote colorectal cancer progression.
Lin K; Zhao Y; Tang Y; Chen Y; Lin M; He L
Cell Death Dis; 2024 Jan; 15(1):85. PubMed ID: 38267463
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial-Mesenchymal Transition.
Chuang KT; Chiou SS; Hsu SH
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444447
[TBL] [Abstract][Full Text] [Related]
9. Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity.
Yan YC; Meng GX; Yang CC; Yang YF; Tan SY; Yan LJ; Ding ZN; Ma YL; Dong ZR; Li T
Cell Death Dis; 2023 Jul; 14(7):404. PubMed ID: 37414748
[TBL] [Abstract][Full Text] [Related]
10. Hsa_circ_0014784-induced YAP1 promoted the progression of pancreatic cancer by sponging miR-214-3p.
Liu B; Gong Y; Jiang Q; Wu S; Han B; Chen F; Lin Q; Wang P; Yang D
Cell Cycle; 2023 Jul; 22(13):1583-1596. PubMed ID: 37318258
[TBL] [Abstract][Full Text] [Related]
11. ITGA3 acts as a purity-independent biomarker of both immunotherapy and chemotherapy resistance in pancreatic cancer: bioinformatics and experimental analysis.
Zheng X; Du Y; Liu M; Wang C
Funct Integr Genomics; 2023 Jun; 23(2):196. PubMed ID: 37270717
[TBL] [Abstract][Full Text] [Related]
12. The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis.
Yoshimura T; Li C; Wang Y; Matsukawa A
Cell Mol Immunol; 2023 Jul; 20(7):714-738. PubMed ID: 37208442
[TBL] [Abstract][Full Text] [Related]
13. Research progress of traditional Chinese medicine as sensitizer in reversing chemoresistance of colorectal cancer.
Lin X; Yang X; Yang Y; Zhang H; Huang X
Front Oncol; 2023; 13():1132141. PubMed ID: 36994201
[TBL] [Abstract][Full Text] [Related]
14. Effect of ZEB1 Associated with microRNAs on Tumor Stem Cells in Head and Neck Cancer.
Ferreira LAM; Bezerra MADS; Kawasaki-Oyama RS; Fernandes GMM; Castanhole-Nunes MMU; Serafim Junior V; Castilho RM; Pavarino ÉC; Maniglia JV; Goloni-Bertollo EM
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982993
[TBL] [Abstract][Full Text] [Related]
15. ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma.
Lin S; Chen Q; Tan C; Su M; Min L; Ling L; Zhou J; Zhu T
BMC Med Genomics; 2024 Jun; 17(1):153. PubMed ID: 38840097
[TBL] [Abstract][Full Text] [Related]
16. miR-34b-5p suppresses the epithelial-mesenchymal transition and metastasis in endometrial cancer AN3CA cells by targeting
Shi L; Yang D; Dong H; Zhang X; Yang C
Int J Clin Exp Pathol; 2024; 17(4):137-150. PubMed ID: 38716353
[TBL] [Abstract][Full Text] [Related]
17. CD73 mitigates ZEB1 expression in papillary thyroid carcinoma.
Vedovatto S; Oliveira FD; Pereira LC; Scheffel TB; Beckenkamp LR; Bertoni APS; Wink MR; Lenz G
Cell Commun Signal; 2024 Feb; 22(1):145. PubMed ID: 38388432
[TBL] [Abstract][Full Text] [Related]
18. Unveiling the mechanisms and challenges of cancer drug resistance.
Khan SU; Fatima K; Aisha S; Malik F
Cell Commun Signal; 2024 Feb; 22(1):109. PubMed ID: 38347575
[TBL] [Abstract][Full Text] [Related]
19. Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies.
Ambrosini G; Cordani M; Zarrabi A; Alcon-Rodriguez S; Sainz RM; Velasco G; Gonzalez-Menendez P; Dando I
Cell Commun Signal; 2024 Jan; 22(1):36. PubMed ID: 38216942
[TBL] [Abstract][Full Text] [Related]
20. Altered Phenotypes of Breast Epithelial × Breast Cancer Hybrids after ZEB1 Knock-Out.
Merckens A; Sieler M; Keil S; Dittmar T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
